연구

연구업적

최근 5년 연구업적 현황
연도 2025년 2024년 2023년 2022년 2021년
SCI 논문
발표편수
책임 196편 179편 173편 163편 184편
공동 132편 147편 120편 115편 136편
합계 328편 326편 293편 278편 320편
2775. Oncologic Benefits of Neoadjuvant Treatment versus Upfront Surgery in Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis.
Jung, H.-S.; Kim, H.S.; Kang, J.S.; Kang, Y.H.; Sohn, H.J.; Byun, Y.; Han, Y.; Yun, W.-G.; Cho, Y.J.; Lee, M.; Kwon, W.; Jang, J.-Y.
. Cancers 2022, 14, 4360. https://doi.org/10.3390/cancers14184360 Link
2774. Impact of surgery on survival outcomes for Bismuth type IV Klatskin tumors.
Choi YJ, Lee JM, Kang JS, Sohn HJ, Byun Y, Han Y, Kim H, Kwon W, Jang JY.
J Gastrointest Surg. 2022 Jun 9. doi: 10.1007/s11605-022-05293-1. Link
2773. Can Surgical Resection of Metastatic Lesions Be Beneficial to Pancreatic Ductal Adenocarcinoma Patients with Isolated Lung Metastasis?
Yun WG, Kwon W, Han Y, Sohn HJ, Kim HS, Lee M, Kim H, Thomas AS, Kluger MD, Jang JY.
Cancers (Basel). 2022 Apr 20;14(9):2067. Link
2772. Prediction of malignancy in Main duct or Mixed-type Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Jung HS, Han Y, Kang JS, Sohn H, Lee M, Lee KB, Kim H, Kwon W, Jang JY.
Ÿ  J Hepatobiliary Pancreat Sci. 2022 Apr 22. Epub ahead of print. Link
2771. Comparison of oncologic outcomes between open and laparoscopic distal pancreatectomy for pancreatic ductal adenocarcinoma using data from the KOTUS-BP national database: overcoming selection bias and the necessity of definite indications.
Kim H, Heo JS, Kang CM, Hwang HK, Han HS, Yoon YS, Park JS, Han SS, Kim YH, Lee HK, Yu YD, Choi IS, Yang JD, Roh Y, Kim SR, Chung J, Song SH, Kim SC, Jang JY.
HPB (Oxford). 2022 Jan 26:S1365-182X(22)00046-6. Link
2770. The incidence and clinical features of familial pancreatic cancer in Korea.
Kim M, Kim H, Han Y, Sohn HJ, Lee M, Kang YH, Kim HS, Kwon W, Jang JY.
J Hepatobiliary Pancreat Sci. 2022 Jan 21. doi: 10.1002/jhbp.1117. Link
2769. The development and clinical efficacy of simulation training of open duct-to-mucosa pancreaticojejunostomy using pancreas and intestine silicone models.
Kang JS, Sohn HJ, Choi YJ, Byun Y, Lee JM, Lee M, Kang YH, Kim HS, Han Y, Kim H, Kwon W, Jang JY.
Ann Surg Treat Res. 2022 Jun;102(6):328-334. Link
2768. Predicting prognosis and evaluating the benefits of adjuvant chemotherapy depending on the tumor location in intrahepatic cholangiocarcinoma: focusing on the involvement of below 2nd bile duct confluence.
Sohn HJ, Kim H, Kim JR, Kang JS, Han Y, Lee M, Kim HS, Kwon W, Hong SK, Choi Y, Yi NJ, Lee KW, Suh KS, Jang JY.
Ann Surg Treat Res. 2022 May;102(5):248-256. Link
2767. In vivo study for the hemostatic efficacy and foreign body reaction of a new powder-type polysaccharide hemostatic agent.
Byun Y, Kim EJ, Lee A, Suh YA, Sohn HJ, Lee JM, Kang JS, Choi YJ, Han Y, Kim H, Kwon W, Jang JY.
Ann Surg Treat Res. 2022 Feb;102(2):65-72. Link
2766. Comparison of oncologic outcomes of extrahepatic cholangiocarcinoma according to tumor location: perihilar cholangiocarcinoma versus distal bile duct cancer.
Lee JM, Kim H, Sohn HJ, Choi HJ, Kang JS, Han Y, Kwon W, Jang JY.
Ann Surg Treat Res. 2022 Feb;102(2):100-109. Link